Limited Pradaxa Recall Issued over Effectiveness Concerns

The Pradaxa Resource Center is the Webs largest source for information on Pradaxa legal news, research and side effects. Visit http://www.Pradaxa-lawsuits.org.

(PRWEB) November 15, 2012

The report comes as The Journal for The American Medical Association warned in September that the FDA may have rushed approval of Pradaxa, overlooking key Pradaxa side effects like internal bleeding. The FDA warned on December 7, 2011 that it was investigating Pradaxa after receiving more injury or death reports than expected.

Anyone affected by internal bleeding after taking Pradaxa is urged to speak with a lawyer about their legal options as soon as possible.

While all anticoagulants can cause internal bleeding, the Journal of Neurosurgery reported doctors concerns on March 6, 2012 that, once Pradaxa causes internal bleeding, there is little they can do to stop it.

Judge Herndon previously issued an order on July 24, 2012 that those injured by Pradaxa can proceed with lawsuits. Due to the number of Pradaxa lawsuits expected, a central court was recently established in Illinois to handle the claims. The case is known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

A report issued by the Institute for Safe Medicine Practices QuarterWatch (PDF) on October 3, 2012 estimates that Pradaxa is among the drugs responsible for a 37% increase in prescription drug complaints to the FDA in recent years.

Anyone affected by internal bleeding after Pradaxa use is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of these federal MDL cases, the Pradaxa Resource Center only recommends lawyers who are already handling Pradaxa lawsuits.

For more information on the research, warnings, side effects and legal options relating to the drug Pradaxa, or to speak with a lawyer, visit http://www.Pradaxa-lawsuits.org.

Patient Advocate Pradaxa Resource Center 877-227-8450 Email Information

See the rest here:
Limited Pradaxa Recall Issued over Effectiveness Concerns